Douglas Jermasek
Förmögenhet: 87 675 $ per 2026-07-31
Förmögenhet: 87 675 $ per 2026-07-31
Douglas Jermasek currently works at Unicycive Therapeutics, Inc., as Executive Vice President-Corporate Strategy from 2021.
Mr. Jermasek also formerly worked at Deltanoid Pharmaceuticals, Inc., as Chief Executive Officer, Keryx Biopharmaceuticals, Inc., as Vice President-Marketing & Strategy from 2016 to 2018, Genzyme Corp., as Senior Vice President & General Manager, and Akebia Therapeutics, Inc., as Senior Vice President-Marketing & Strategy.
Mr. Jermasek received his undergraduate degree from Brigham Young University and Masters Business Admin degree from BYU Marriott School.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-14 | 17 500 ( 0,07 % ) | 87 675 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Företagsledare/Principal | 2021-11-01 |
| Företag | Position | Slut |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Försäljning & Marknadsföring | 2018-12-12 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | - |
| AKEBIA THERAPEUTICS, INC. | Försäljning & Marknadsföring | - |
Deltanoid Pharmaceuticals, Inc.
Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops therapies for the treatment of human diseases | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deltanoid Pharmaceuticals, Inc.
Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops therapies for the treatment of human diseases | Commercial Services |
Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
BYU Marriott School
BYU Marriott School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån